Chemomab Therapeutics (CMMB) Asset Writedowns and Impairment (2018 - 2020)
Chemomab Therapeutics (CMMB) posted Asset Writedowns and Impairment of $83000.0 for Q1 2020, up 100.37% on a QoQ basis from -$22.5 million in Q4 2019.
Chemomab Therapeutics (CMMB) Asset Writedowns and Impairment (2018 - 2020) Analysis & Trends
Chemomab Therapeutics' Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $83000.0 for Q1 2020.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $83000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was -$9.3 million (changed N/A YoY) and the FY2020 annual result came in at $278000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was $83000.0 for Q1 2020 at Chemomab Therapeutics, up from -$22.5 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $12.4 million in Q3 2019 and bottomed at -$22.5 million in Q4 2019.
- A 3-year average of -$2.3 million and a median of $386500.0 in 2018 frame the typical range for Asset Writedowns and Impairment.
- Peak annual rise in Asset Writedowns and Impairment reached 1698.99% in 2019, while the deepest fall reached 1698.99% in 2019.
- Chemomab Therapeutics' Asset Writedowns and Impairment stood at $690000.0 in 2018, then sank by 3365.36% to -$22.5 million in 2019, then soared by 100.37% to $83000.0 in 2020.
- Business Quant data shows CMMB's Asset Writedowns and Impairment at $83000.0 in Q1 2020, -$22.5 million in Q4 2019, and $12.4 million in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Chemomab Therapeutics | 729.63 Mn | 719.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 83,000.00 |
| Mar 31, 2020 | 83,000.00 |
| Dec 31, 2019 | -22.53 Mn |
| Dec 31, 2019 | -22.53 Mn |
| Sep 30, 2019 | 12.41 Mn |
| Sep 30, 2019 | 12.41 Mn |
| Sep 30, 2018 | 690,000.00 |
| Sep 30, 2018 | 690,000.00 |